heart healthy News
-
CDC issues mixed assessment of US vitamin intake
According to the Second National Report on Biochemical Indicators of Diet and Nutrition, released today by the Centers for Disease Control and Prevention, the US population has good levels of vitamins A and D and folate in the body, but some groups still need to increase their levels of vitamin D and iron. The report offered a limited but generally favorable review of the nation's nutrition ...
By BIO-CAT
-
Hextransforma Healthcare National Walking Month
May is National Walking Month and we are encouraging all our employees to lace up their shoes, enjoy some: fresh air and fundraise for Diabetes UK. Asa pioneer in Quality of Movement research, we want to highlight the importance of walking in maintaininga good qualityof life and are pledging to walk 3 million steps in 31 days to raise £300 for Diabetes UK, our charity partner. Most people ...
-
Jiffy Lube surpasses $1 million fundraising goal for the American Heart Association`s go red for women movement to fight heart disease
As a result of the generous support of its customers across the country, Jiffy Lube proudly announces that its 2010 Maintenance Partners for Life campaign raised more than $1 million for the American Heart Association's (AHA) Go Red For Women movement -- for a third year. More than 1,700 Jiffy Lube service centers participated in the campaign, which helps raise awareness and funds to fight heart ...
-
BioVentrix Receives 2021 NUB Status 1 Reimbursement Renewal in Germany for the Revivent TC TransCatheter Ventricular Enhancement System
BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure (CHF) via Transcatheter based Ventricular Restoration (TCVR), today announced that the German Institute for Hospital Remuneration (InEK) has renewed the NUB Status 1 reimbursement designation in Germany for the Revivent TC™ TransCatheter Ventricular Enhancement System used in LIVE™ ...
-
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes
Ncardia and BlueRock Therapeutics today announced an agreement covering process development technologies for the manufacture of induced pluripotent stem cell (iPSC)-derived cardiomyocytes. Under the terms of the agreement, Bluerock gains access to Ncardia’s large-scale production processes and intellectual property for the production of iPSC-derived cardiomyocytes for therapeutic use. ...
-
Odin`s CEO speaks at MD&M West 2020
Sensor advancements are driving innovation in both wearable devices and surgical devices. Speakers at the MD&M West 2020 conference explore several developments. The role of sensors in medical devices is becoming increasingly more important, especially when it comes to developing new technologies such as wearable devices that can diagnose and transmit information for long periods of ...
-
BioVentrix Announces Ralph Stephan von Bardeleben, MD, as Co- Principal Investigator of the REVIVE-HF Clinical Trial
BioVentrix, Inc., developer of the first transcatheter device for left ventricular remodeling after a heart attack, today announced that Ralph Stephan von Bardeleben, MD, of the University Medical Center of Mainz (Germany) has joined the European REVIVE-HF clinical trial of the Revivent TC™ Transcatheter Ventricular Enhancement System as co-principal investigator. Dr. von Bardeleben heads ...
-
FierceMedTech Names BioVentrix as One of Its “Fierce 15” Companies of 2019
BioVentrix, Inc., developer of the first hybrid transcatheter device for left ventricular remodeling after a heart attack, today announced that it has been named by FierceMedTech as one of the “Fierce 15” for 2019, designating it as one of the most promising private medtech companies in the industry. The company offers Less Invasive Ventricular Enhancement, or the LIVE™ ...
-
Supira Medical, A Shifamed Portfolio Company, Closes $35M in Series B Financing
Company Appoints Seasoned Medtech Executive as President and CEO CAMPBELL, Calif., March 5, 2020 – Supira Medical, formed by Shifamed as part of its medical innovation hub, announced today the closing of $35M in Series B financing. Officially closed on February 25, the financing was led by Cormorant Asset Management with participation from The Capital Partnership (TCP), 415 CAPITAL, AMED ...
-
NIH statement on Asthma Awareness Month
For Asthma Awareness Month 2013, the National Institutes of Health stands with the international community to renew our dedication to improving the quality of life for the estimated 300 million people living with asthma worldwide. To most effectively manage asthma, we need to address the disproportionate impact of the disease on minorities and families at or below the poverty line. NIH is ...
-
Asthma Awareness Month 2014: NIH Continues its Commitment to Asthma Research
May is Asthma Awareness Month, and the National Institutes of Health emphasizes the scientific progress being made in asthma research, from basic science, such as how lung cells work, to clinical trials on current and future treatments for the disease. NIH-led research includes studies of environmental factors, how the body’s own defense system plays a role, and the microbiome — all ...
-
XyloCor Therapeutics Completes Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease
Company closes additional $22.6 million in new financing Proceeds will fund initiation of new clinical trial for lead gene therapy candidate XC001 as adjunctive therapy for patients undergoing coronary artery bypass graft surgery XyloCor Therapeutics, a private clinical-stage biopharmaceutical company focused on the development of gene therapy for the significant unmet patient needs in ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you